Sources

7 Total Sources

Moderna, Merck Post Positive Phase 3 Melanoma Data in 1,137-Patient AI-Personalized Therapy Trial

Moderna, Merck Announce Positive Phase 3 Results for AI-Personalized Melanoma Therapy

The Japan Times21h ago

BioNTech lung cancer drug extends survival versus chemotherapy - The Japan Times

Simply Wall St3h ago

Moderna (MRNA) Is Up 151.8% After First Positive Phase 3 mRNA Cancer Therapy Result - What's Changed - Simply Wall St News

Moderna, Merck cancer vaccine shows initial late-stage melanoma data

The Boston Globe3h ago

Moderna cancer vaccine results could herald new world of treatment

National Geographic3h ago

New Cancer Vaccine Shows Promise Against Melanoma. Here's How It Works. | National Geographic

BioSpace17h ago

5 drugmakers chasing Merck and Moderna in the cancer vaccine race - BioSpace